Volume 13, Issue 1

Neurotherapeutics is now archived and no longer receiving submissions with this publisher. All articles published in the journal during its time with Springer will remain fully searchable through our websites.

Search all Neurotherapeutics articles

January 2016

Immunotherapy of Neurological Diseases

24 articles in this issue

Neuro-Immunotherapies: A 30-year Retrospective of an Overwhelming Success and a Brighter Future
Marinos C. Dalakas
Editorial 18 December 2015 Pages: 1 - 3
Neuroimmunotherapies Targeting T Cells: From Pathophysiology to Therapeutic Applications
Stefan Bittner
Heinz Wiendl
Review 12 November 2015 Pages: 4 - 19
Anti-B-Cell Therapies in Autoimmune Neurological Diseases: Rationale and Efficacy Trials
Harry Alexopoulos
Angie Biba
Marinos C. Dalakas
Review 13 November 2015 Pages: 20 - 33
Efficacy of Intravenous Immunoglobulin in Neurological Diseases
Jan D. Lünemann
Isaak Quast
Marinos C. Dalakas
Review 23 September 2015 Pages: 34 - 46
Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple Sclerosis
Jens Ingwersen
Orhan Aktas
Hans-Peter Hartung
Review 23 December 2015 Pages: 47 - 57
Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis
Afsaneh Shirani
Darin T. Okuda
Olaf Stüve
Review 04 January 2016 Pages: 58 - 69
Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders
Ingo Kleiter
Ralf Gold
Review 23 November 2015 Pages: 70 - 83
Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis
J. Nicholas Brenton
Brenda L. Banwell
Review 23 October 2015 Pages: 84 - 95
Immunotherapy in Peripheral Neuropathies
Jean-Marc Léger
Raquel Guimarães-Costa
Cristina Muntean
Review 24 November 2015 Pages: 96 - 107
Immunotherapy Prospects for Painful Small-fiber Sensory Neuropathies and Ganglionopathies
Anne Louise Oaklander
Review 02 November 2015 Pages: 108 - 117
Current Treatment, Emerging Translational Therapies, and New Therapeutic Targets for Autoimmune Myasthenia Gravis
Jeffrey T. Guptill
Madhu Soni
Matthew N. Meriggioli
Review 28 October 2015 Pages: 118 - 131
Immunotherapies for Immune-Mediated Myopathies: A Current Perspective
Merrilee Needham
Frank L. Mastaglia
Review 19 November 2015 Pages: 132 - 146
Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies
Matteo Gastaldi
Anaïs Thouin
Angela Vincent
Review Open access 21 December 2015 Pages: 147 - 162
Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity
Eleni I. Kampylafka
Harry Alexopoulos
Athanasios G. Tzioufas
Review 28 October 2015 Pages: 163 - 178
Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders
Elvira Valera
Brian Spencer
Eliezer Masliah
Review 22 October 2015 Pages: 179 - 189
Precision Medicine: SCN8A Encephalopathy Treated with Sodium Channel Blockers
Rikke S. Møller
Katrine M. Johannesen
Commentary 09 November 2015 Pages: 190 - 191
Remarkable Phenytoin Sensitivity in 4 Children with SCN8A-related Epilepsy: A Molecular Neuropharmacological Approach
Ragna S. Boerma
Kees P. Braun
Bobby P. C. Koeleman
Original Article Open access 09 August 2015 Pages: 192 - 197
Chronic Treatment with the AMPK Agonist AICAR Prevents Skeletal Muscle Pathology but Fails to Improve Clinical Outcome in a Mouse Model of Severe Spinal Muscular Atrophy
Clàudia Cerveró
Neus Montull
Jordi Calderó
Original Article 18 November 2015 Pages: 198 - 216
Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal Fluid
Reno C. Reyes
Giordano Fabricio Cittolin-Santos
Raymond A. Swanson
Original Article 16 November 2015 Pages: 217 - 225
Improved Treatment Efficacy of Antiangiogenic Therapy when Combined with Picornavirus Vaccination in the GL261 Glioma Model
Danielle N. Renner
Courtney S. Malo
Aaron J. Johnson
Original Article 30 November 2015 Pages: 226 - 236
Erratum to: Interaction of Paroxetine with Mitochondrial Proteins Mediates Neuroprotection
Joseph P. Steiner
Muznabanu Bachani
Avindra Nath
Erratum 21 December 2015 Pages: 237 - 237
Erratum to: Remarkable Phenytoin Sensitivity in 4 Children with SCN8A-related Epilepsy: A Molecular Neuropharmacological Approach
Ragna S. Boerma
Kees P. Braun
Bobby P. C. Koeleman
Erratum 22 August 2015 Pages: 238 - 238
Erratum to: Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal Fluid
Reno C. Reyes
Giordano Fabricio Cittolin-Santos
Raymond A. Swanson
Publisher's Erratum 09 December 2015 Pages: 239 - 239
PROGRAM

News 28 September 2015 Pages: 240 - 260

Volume 13, Issue 1

Neuro-Immunotherapies: A 30-year Retrospective of an Overwhelming Success and a Brighter Future

Neuroimmunotherapies Targeting T Cells: From Pathophysiology to Therapeutic Applications

Anti-B-Cell Therapies in Autoimmune Neurological Diseases: Rationale and Efficacy Trials

Efficacy of Intravenous Immunoglobulin in Neurological Diseases

Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple Sclerosis

Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis

Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders

Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis

Immunotherapy in Peripheral Neuropathies

Immunotherapy Prospects for Painful Small-fiber Sensory Neuropathies and Ganglionopathies

Current Treatment, Emerging Translational Therapies, and New Therapeutic Targets for Autoimmune Myasthenia Gravis

Immunotherapies for Immune-Mediated Myopathies: A Current Perspective

Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies

Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity

Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders

Precision Medicine: SCN8A Encephalopathy Treated with Sodium Channel Blockers

Remarkable Phenytoin Sensitivity in 4 Children with SCN8A-related Epilepsy: A Molecular Neuropharmacological Approach

Chronic Treatment with the AMPK Agonist AICAR Prevents Skeletal Muscle Pathology but Fails to Improve Clinical Outcome in a Mouse Model of Severe Spinal Muscular Atrophy

Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal Fluid

Improved Treatment Efficacy of Antiangiogenic Therapy when Combined with Picornavirus Vaccination in the GL261 Glioma Model

Erratum to: Interaction of Paroxetine with Mitochondrial Proteins Mediates Neuroprotection

Erratum to: Remarkable Phenytoin Sensitivity in 4 Children with SCN8A-related Epilepsy: A Molecular Neuropharmacological Approach

Erratum to: Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal Fluid

PROGRAM

Navigation